Navigation Links
Game-Based Technology to Meet Demand for Improved Medical Teaching and Training
Date:5/5/2008

BreakAway Gains Exclusive License for Pulse!! Virtual Learning Platform for

Clinical Skills and Decision Making Training

BALTIMORE, May 5 /PRNewswire/ -- BreakAway Ltd., a leading developer of game-based technology solutions for training, experimentation and decision-making analysis, has signed a license agreement with the Texas A&M University System for the exclusive, worldwide rights to Pulse!! the Virtual Clinical Learning Lab, a federally-funded project in development at Texas A&M University-Corpus Christi (TAMU-CC). This agreement grants BreakAway the rights to develop, market and distribute Pulse!!, the innovative, game-based platform technology that allows medical professionals to practice decision-making protocol and experiential skills on their PCs, in a virtual hospital setting, anywhere, at anytime, in a safe learning environment.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080505/NEM088-a )

(Logo: http://www.newscom.com/cgi-bin/prnh/20080505/NEM088LOGO-b )

BreakAway CEO Doug Whatley said, "Through our collaboration with TAMU-CC to develop a platform solution for teaching and training medical professionals, we realize the urgent need for medical organizations to augment their traditional training methods with game-based technology such as Pulse!!. We are honored to be able to use Pulse!! technology as the starting point for delivering virtual learning tools to supplement medical training using a simulated 3D world that replicates the actual physical and emotional environment that medical professionals face whether it's in a hospital, clinic or on the battlefield."

The Pulse!! project was pioneered and is directed by Dr. Claudia L. McDonald, Associate Vice President for Special Projects at TAMU-CC, in order to address educational and
'/>"/>

SOURCE BreakAway Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Medical Technology is Changing the Face of Wrinkle Treatment
2. Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc.
3. US Army Purchases SeQuals Cutting-Edge Oxygen Generation Technology for MRAP Deployment
4. Astute Nanotechnology celebrates first year of success
5. BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology
6. Columbia River Resources Inc subsidiary, Traxxec Ltd, reports coverage of its technology at Interpack 2008 (Pink Sheets OTC - CRVR.pk)
7. Invention gives improved gene technology analysis
8. Key Industry and Government Officials to Address Medical Technology Executives
9. FDA Approval of Cimzia(R) for Crohns Disease Represents Latest Milestone for Nektars PEGylation Technology Platform
10. Perot Systems and Surgical Care Affiliates Sign Five-Year Agreement to Implement Advanced Technology Solutions
11. ANSYS Technology Offers Swimmers Best Chance of Success in Build-Up to Beijing Games
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 Fundraising support for ... greater gains than losses. At noon on Monday, November 10 ... Hospital (SSMH), greater than 20 Susquehanna Health (SH) employees ... to raise awareness and funds for the new Cancer Center ... participants’ heads for this act of love and support to ...
(Date:10/31/2014)... for Healthy Neighborhoods (PRCHN) at Case Western Reserve ... in nearly $13.32 million in federal grants awarded ... The Centers for Disease Control and Prevention (CDC) ... five years. The funds will support the center,s ... environmental, and policy interventions that prevent and reduce ...
(Date:10/31/2014)... Monica Williams-Murphy MD , advanced care planning ... chaos that can occur for people who have not ... Americans who come into the emergency department facing the ... the moment and so are their families." She adds, ... catalyst for a family to get the critical conversations ...
(Date:10/31/2014)... 31, 2014 Activz Whole-Food Nutrition ... Silver line offering natural silver healing support† in ... a century, silver has been used to support natural ... products is the most advanced version available. This latest ... chemical structure that supports the existing healing mechanisms in ...
(Date:10/31/2014)... increases the risk of certain types of breast cancer ... studies show. One study of more than 3,200 ... risk for estrogen receptor-negative and progesterone receptor-positive breast tumors ... long time for white women, but now we are ... John, a senior research scientist at the Cancer Prevention ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2
... exercised during pregnancy needed less pain meds, study found ... during pregnancy reduces the amount of pain-killing medication requested ... that included 71 expectant mothers. , Half the ... week of aquarobics during their pregnancy, while the other ...
... the Dallas office of WHR Architects. Ms. Moran, nationally recognized ... Education, Science and Technology practice and broaden the talent base ... , "Anita,s experience and skills complement ... college and university clients," said Mark W. Vaughan AIA, ACHA, ...
... SPRINGFIELD, Mass., Nov. 21 Massachusetts Mutual Life,Insurance ... two,Co-Chief Operating Officers. , ... Officer, Executive Vice President,and Chief Investment Officer, will ... H. Reese, who remains Chairman and Chief Executive,Officer. ...
... NXTM ), a leading manufacturer of innovative ... 2008 Technology Fast 500, a,ranking of the 500 fastest ... America. Rankings are based on percentage of,fiscal year revenue ... more than 20,000 percent during this period. , ...
... by HIV/AIDS in New Jersey and Africa - , ... than 800 local Roche employees are participating in the ... support children infected and affected by HIV/AIDS in New Jersey and ... through the township of Nutley, collect donations for their efforts, and ...
... to take, has fewer side effects than chemotherapy, ... The cancer-fighting pill Iressa works as well as chemotherapy ... , Although neither therapy prolongs survival beyond eight months, ... be a better choice for patients who did not ...
Cached Medicine News:Health News:Aquarobics May Help Ease Labor 2Health News:Anita Moran AIA Joins WHR Dallas 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 3Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 4Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 5Health News:NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 2Health News:NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 3Health News:Roche Holds Sixth Annual Children's Walk in Nutley 2Health News:Roche Holds Sixth Annual Children's Walk in Nutley 3Health News:Roche Holds Sixth Annual Children's Walk in Nutley 4Health News:Iressa as Good as Chemotherapy for Lung Cancer 2Health News:Iressa as Good as Chemotherapy for Lung Cancer 3
(Date:10/31/2014)... Mich. , Oct. 31, 2014  Lycera ... modulators to treat autoimmune disease and cancer, today ... novel synthetic RORgamma agonist product candidates will be ... for Immunotherapy of Cancer (SITC) being held November ... Convention Center, National Harbor, MD.  The poster, entitled ...
(Date:10/31/2014)... -- British Journal of Urology International ... "male orgasmic dysfunction" with their doctor prior to any ... while preserving sexual function     ... paper in the British Journal of Urology International which ... with their doctors the likely impact of treatment options ...
(Date:10/31/2014)... DUBLIN , October 30, 2014 ... ) has announced the addition of the  "Process ...  conference to their offering.      (Logo: ... , Science and Risk Based Approach to Process ... Quality Risk Management FDA Process Validation ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4
... 29, 2010 Reportlinker.com announces that a new ... 2010-2015 In-depth Research Report on ... http://www.reportlinker.com/p0356862/2010-2015-In-depth-Research-Report-on-China-Sodium-Fluoride-Industry.html Report SummaryBased on ... Bureau, General Administration of Custom, Ministry of Commerce ...
... Reportlinker.com announces that a new market research report ... The Outlook for Pharmaceuticals to 2012 ... Pharmaceuticals to 2012 is a new collection of management ... individual and highly-detailed analysis of each market, looking at ...
Cached Medicine Technology:Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 2Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 3Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 4Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 5
Toxoplasma IgM II ELISA....
HSV 1 & HSV 2 DFA Test....
Herpes Simplex Virus 2 IgG ELISA....
Herpes Simplex Virus 1 IgG ELISA....
Medicine Products: